concept

ADUCANUMAB

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ADUCANUMAB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

95Connections

0Hypotheses

0Analyses

50Outgoing

22Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	ADUCANUMAB
Key Genes/Proteins	AMYLOID, AMYLOID-BETA, APOE, APP, BACE1, BDNF
Related Diseases	AGING, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID PLAQUES, COGNITIVE DECLINE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Aduhelm

entity · 2483 words

→

Pathway Diagram

graph TD
    ADUCANUMAB["ADUCANUMAB"]
    ADUCANUMAB -->|"targets"| AMYLOID_BETA["AMYLOID-BETA"]
    ADUCANUMAB -->|"treats"| Alzheimer_S_Disease["Alzheimer'S Disease"]
    ADUCANUMAB -->|"treats"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
    ADUCANUMAB -->|"target for"| LECANEMAB["LECANEMAB"]
    ADUCANUMAB -->|"inhibits"| Amyloid["Amyloid"]
    ADUCANUMAB -->|"regulates"| terminally_inflammatory_microg["terminally inflammatory microglia"]

Outgoing (73)

Target	Relation	Type	Str
ad_clinical_trial_failures:aducanumab	data_in	dataset_row	0.00
ad_clinical_trial_failures:aducanumab	data_in	dataset_row	0.00
AMYLOID-BETA	targets	protein	0.90
Amyloid-β	targets	protein	0.90
ALZHEIMER'S DISEASE	treats	disease	0.85
Alzheimer'S Disease	treats	disease	0.85
Amyloid-Β	targets	compound	0.85
LECANEMAB	targets	drug	0.80
ubiquitin-proteasome	modulates	pathway	0.75
neuroinflammation	treats	disease	0.75
Amyloid	implicated_in	entity	0.70
Amyloid	biomarker_for	entity	0.70
Amyloid	inhibits	entity	0.70
terminally inflammatory microglia	regulates	cell_type	0.70
neurodegeneration	treats	disease	0.65
blood-brain barrier	modulates	pathway	0.65
STING	inhibits	gene	0.65
ALZHEIMER	targets	disease	0.65
ALZHEIMER'S DISEASE	targets	disease	0.65
CAPZB	targets	gene	0.60
GDI2	targets	gene	0.60
PLCB1	targets	gene	0.60
HK1	targets	gene	0.60
NDUFA4	targets	gene	0.60
MAG	targets	gene	0.60
CD81	targets	gene	0.60
NDUFS7	targets	gene	0.60
Alzheimer's disease	treats	disease	0.60
AMYLOID	associated_with	protein	0.60
Parkinson's disease	treats	disease	0.60
HK2	targets	gene	0.55
TREM2	targets	gene	0.55
BACE1	targets	gene	0.55
BDNF	targets	gene	0.55
NGF	targets	gene	0.55
neurotrophin signaling	modulates	pathway	0.55
insulin signaling	modulates	pathway	0.55
APOE4	targets	gene	0.55
APP	targets	gene	0.55
PS1	targets	gene	0.55
ANXA1	targets	gene	0.55
purinergic signaling	modulates	pathway	0.55
HSP70	targets	gene	0.55
mitochondrial function	modulates	pathway	0.55
epigenetic regulation	modulates	pathway	0.55
HDAC	targets	gene	0.55
DONANEMAB	therapeutic_target	drug	0.50
MICROGLIA	associated_with	cell_type	0.50
BDNF	associated_with	gene	0.50
NGF	associated_with	gene	0.50

Incoming (22)

Source	Relation	Type	Str
ad_clinical_trial_failures:aducanumab	data_in	dataset_row	0.00
ad_clinical_trial_failures:aducanumab	data_in	dataset_row	0.00
HK2	inhibits	gene	0.70
COGNITIVE DECLINE	interacts_with	phenotype	0.70
PARKINSON'S DISEASE	targets	disease	0.65
DONANEMAB	causes	drug	0.65
DONANEMAB	treats	drug	0.65
CSF	interacts_with	phenotype	0.60
CSF	synergizes_with	phenotype	0.60
COGNITIVE DECLINE	associated_with	phenotype	0.50
NEURODEGENERATION	associated_with	phenotype	0.50
MITOCHONDRIAL DYSFUNCTION	associated_with	phenotype	0.50
PROTEIN AGGREGATION	associated_with	phenotype	0.50
PROTEOSTASIS	associated_with	phenotype	0.50
NEUROINFLAMMATION	associated_with	phenotype	0.50
PARKINSON'S DISEASE	associated_with	disease	0.50
ALZHEIMER'S DISEASE	associated_with	disease	0.45
GANTENERUMAB	associated_with	drug	0.45
SOLANEZUMAB	associated_with	drug	0.45
AMYLOID-BETA	associated_with	protein	0.45
AMYLOID PLAQUES	associated_with	phenotype	0.45
MULTIPLE SCLEROSIS	associated_with	disease	0.45

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning ADUCANUMAB in their description or question text

No additional research found